Xavier Llor - Concepedia

Author

Xavier Llor

Yale University ORCID

Also Known As

Llor, Xavier, Sandler, Robert S., X Llor, X. Llor, Xavier Llor

112

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Yale University Yale Cancer Center Smilow Cancer Hospital The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Fred Hutch Cancer Center

About

Xavier Llor is an author at Yale University specializing in medicine, gastroenterology, and colorectal cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	1.3K
2	Gastroenterology	10	11	1.3K
3	Public Health	6	6	947
4	Epidemiology	4	4	768
5	Cell Biology	2	2	231

Xavier Llor

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019 Samir Gupta, Dawn Provenzale, Xavier Llor, Journal of the National Comprehensive Cancer Network Genetic TestingNccn Guidelines InsightsGenetic EpidemiologyPathologyGastroenterology	2019	333
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017 Samir Gupta, Dawn Provenzale, Scott E. Regenbogen, Journal of the National Comprehensive Cancer Network Polygenic RiskGenetic EpidemiologyGastroenterologyPathologyNccn Guidelines Insights	2017	212
Race-dependent association of sulfidogenic bacteria with colorectal cancer Patricia G. Wolf, Hajwa Kim, Tzu-Wen Cross, Gut	2017	209
NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020 Dawn Provenzale, Reid M. Ness, Xavier Llor, Journal of the National Comprehensive Cancer Network	2020	184
NCCN Guidelines Insights: Colorectal Cancer Screening, Version 1.2018 Dawn Provenzale, Samir Gupta, Dennis J. Ahnen, Journal of the National Comprehensive Cancer Network Cancer EpidemiologyHealth PolicyCancer ScreeningMedicineNccn Guidelines Insights	2018	169
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021. Jennifer M. Weiss, Samir Gupta, Carol A. Burke, PubMed Nccn Guidelines® InsightsPolygenic RiskGenetic EpidemiologyGastroenterologyPathology	2021	154
BRK/Sik expression in the gastrointestinal tract and in colon tumors. Xavier Llor, Michael S. Serfas, W. Bie, PubMed Brk Tyrosine KinaseBrk/sik ExpressionGastroenterologyPathologyCancer Biology	1999	117
Clinical features and cancer risk in families with pathogenic <i>CDH1</i> variants irrespective of clinical criteria Rosa M. Xicola, Shuwei Li, Nicolette J. Rodriguez, Journal of Medical Genetics	2019	116
Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa. Russell F. Jacoby, Xavier Llor, Ba-Bie Teng, Journal of Clinical Investigation Colon CarcinogenesisCarcinogen InjectionsOncogenic AgentGastrointestinal PharmacologyK-ras Oncogene	1991	114
Analysis of Survival Among Adults With Early-Onset Colorectal Cancer in the National Cancer Database En Cheng, Holly N. Blackburn, Kimmie Ng, JAMA Network Open	2021	104

Page 1